Jackson Grant Investment Advisers’s Regeneron Pharmaceuticals REGN Stock Holding History

Jackson Grant Investment Advisers’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.73K	Hold	14	–	–	﹤0.01%	324
2026 Q1	$10.8K	Hold	14	–	–	﹤0.01%	300
2025 Q4	$10.8K	Sell	14 -3	-18%	-$2.04K	﹤0.01%	293
2025 Q3	$9.56K	Hold	17	–	–	﹤0.01%	299
2025 Q2	$8.93K	Sell	17 -14	-45%	-$7.81K	﹤0.01%	275
2025 Q1	$19.7K	Hold	31	–	–	0.01%	223
2024 Q4	$22.1K	Hold	31	–	–	0.01%	222
2024 Q3	$32.6K	Hold	31	–	–	0.01%	202
2024 Q2	$32.6K	Hold	31	–	–	0.01%	201
2024 Q1	$29.8K	Hold	31	–	–	0.01%	206
2023 Q4	$27.2K	Hold	31	–	–	0.01%	206
2023 Q3	$25.5K	Hold	31	–	–	0.01%	210
2023 Q2	$22.3K	Hold	31	–	–	0.01%	220
2023 Q1	$25.5K	Buy	31 +3	+11%	+$2.26K	0.01%	240
2022 Q4	$20.2K	Hold	28	–	–	0.01%	254
2022 Q3	$19K	Hold	28	–	–	0.01%	261
2022 Q2	$17K	Hold	28	–	–	0.01%	282
2022 Q1	$20K	Hold	28	–	–	0.01%	282
2021 Q4	$18K	Hold	28	–	–	0.01%	246
2021 Q3	$17K	Hold	28	–	–	0.01%	303
2021 Q2	$16K	Buy	28 +4	+17%	+$2.03K	0.01%	321
2021 Q1	$11K	Buy	+24	New	+$11.7K	0.01%	336

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Jackson Grant Investment Advisers's REGN Position: Q2 2026 in Review

Jackson Grant Investment Advisers held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 14 shares worth $8.73K. The position accounts for ﹤0.01% of the portfolio, ranked #324.

Jackson Grant Investment Advisers first reported a position in REGN in Q1 2021 and has held it in 22 quarters since. The position peaked at $32.6K in Q3 2024. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Jackson Grant Investment Advisers held 14 shares of Regeneron Pharmaceuticals worth $8.73K as of Q2 2026.
Jackson Grant Investment Advisers left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
Regeneron Pharmaceuticals made up ﹤0.01% of Jackson Grant Investment Advisers's portfolio in Q2 2026, its #324 holding.
Jackson Grant Investment Advisers first reported a position in Regeneron Pharmaceuticals in Q1 2021 and has held it in 22 quarters since.
Jackson Grant Investment Advisers's Regeneron Pharmaceuticals position peaked at $32.6K in Q3 2024.
518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Jackson Grant Investment Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.